Clinical impact of plasma TGF-β1 and circulating TGF-β1 mRNA in diagnosis of hepatocellular carcinom

来源 :Hepatobiliary & Pancreatic Diseases International | 被引量 : 0次 | 上传用户:supersonic
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
BACKGROUND:Transforming growth factor-β(TGF-β) plays an important role in the regulation of cell growth and differentiation,angiogenesis,extracellular matrix formation,immunosuppression and cancer development. In this study,we investigated the levels of T
其他文献
BACKGROUND:Stent migration in the hepatopancreatic duct might arise as one of the rare complications associated with biliary or pancreatic stenting.Although the
BACKGROUND:Effective measures are lacking to treat long-term poorly closed incisions after hepatobiliary surgery,including chronic sinus tract and keloid.This s
BACKGROUND:Ciliated foregut cysts of the liver are rare, with only 96 cases diagnosed since the first description in 1857.They are being increasingly diagnosed
BACKGROUND:With the improvement of MR technology, three-dimensional dynamic contrast-enhanced MR angiography(3D-DCE-MRA)may be the optimal vascular imaging meth
BACKGROUND: hronic liver disease has been considered a contraindication to radical surgery for intra-abdominal tumors because of the risk of decompensation. MET
BACKGROUND:Although the use of non-heart beating donors(NHBDs)could bridge the widening gap between organ demand and supply,its application to liver transplanta
BACKGROUND:Solitary necrotic nodule of the liver is a rare nonmalignant lesion.The present study aimed to clarify the clinical features of the disease. METHOD:T
Echinococcosis is a severe helminthic zoonosis largely caused by Echinococcus granulosus and frequently encountered in endemic areas.The liver and lung are the
【正】The Liver Transplantation Summit Forum 2009 was held on 8th May,2009 in Hangzhou co-sponsored by Ministry of Health,the Chinese Academy ofEngineering,Grou
期刊
BACKGROUND:Carcinoid tumors of the extrahepatic biliary tree are extremely rare malignancies,accounting for 0.2%-2%of all gastrointestinal carcinoid tumors,whil